Tempus AI stock tumbles 19% in wake of Q4 earnings report
Shares of Tempus AI (NASDAQ:TEM) dropped 19% Tuesday, the day after the AI-focused healthcare company released a Q4 earnings report that missed Street estimates and its 2025 financial forecast. For Q4,
Q4 2024 Tempus AI Inc Earnings Call
At this time, I would like to welcome everyone to the Tempus fourth-quarter 2024 financial results conference call. Thank you, Jason. Good afternoon and welcome to Tempus fourth-quarter 2024 conference call.
Tempus AI Gears Up For Q4 Earnings After 101% YTD Surge
Tempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD. Analysts see 13.5% upside with consensus rating of Buy and $59.60 price target.
Tempus AI down 7% at $64.83 after Q4 earnings miss and guidance
EST Tempus AI (TEM) down 7% at $64.83 after Q4 earnings miss and guidanceDiscover the Best Stocks and Maximize Your Portfolio: See what
Tempus: Q4 Earnings Snapshot
The health care technology company posted revenue of $200.7 million in the period. For the year, the company reported a loss of $705.8 million, or $6.23 per share. Revenue was reported as $693.4 million. Tempus expects full-year revenue of $1.24 billion.
Huron Consulting: Q4 Earnings Snapshot
Huron Consulting Group Inc. (HURN) on Tuesday reported fourth-quarter net income of $34 million. On a per-share basis, the Chicago-based company said it had net income of $1.84. Earnings, adjusted for one-time gains and costs,
Zacks.com on MSN11h
Tempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip?
Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...
Tempus AI: Buying The Dip After 2025 Guidance Raise
Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...
Tempus AI Inc (TEM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Moves
Tempus AI Inc (TEM) reports impressive revenue growth, strategic acquisitions, and extended partnerships, setting the stage for a promising 2025.
Tempus AI reports Q4 adjusted EPS (18c), consensus (15c)
Reports Q4 revenue $200.7M, consensus $202.8M. “Our performance in 2024 reflects the strength of our core businesses, as Genomics continued to ...
Tempus AI Earnings: A Promising Business, But There Are Risks
Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...
1TEM : Tempus AI Q4 Earnings: Revenue Miss, EPS Beat, Strong Guidance, Shares Move Lower
Would you like to be notified of the latest news and updates on the stock market?
Crain's Chicago Business1d
A mixed bag for Tempus AI despite 'fantastic' quarter
Despite filing a fourth-quarter and yearend 2024 earnings report that the CEO described as "fantastic" yesterday afternoon, ...
Tempus AI, Inc. (TEM) Secures $300 Million to Fuel Ambry Genetics Acquisition
We recently published a list of 10 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at ...